Fresenius Medical Care AG & Co. KGaA

Investor Presentation • May 25, 2011

Corporate Profile

Fresenius Medical Care

Fresenius Medical Care is the world's largest integrated provider of products and services for individuals undergoing dialysis because of chronic kidney failure, a condition that affects more than 2 million individuals worldwide. Through its network of 2,769 dialysis clinics in North America, Europe, Latin America, Asia-Pacific and Africa, Fresenius Medical Care provides dialysis treatment to 216,942 patients around the globe. Fresenius Medical Care is also the world's leading provider of dialysis products such as hemodialysis machines, dialyzers and related disposable products.

Growth Strategy

With GOAL 13…

…new targets of the growth strategy were adopted in September 2010. Thereby we follow up the previous strategy, continuing to pursue the strategic four paths consistently in a financially responsible way to consolidate our position as world market leader in dialysis:

• Organic growth in dialysis services by innovative treatment techniques and the opening of new clinics
• Acquisitions of existing clinics to ensure optimized international presence
• Horizontal expansion in the sector of Renal Drugs as well as
• A boosted activity in home therapies

Key Figures - Summary First Quarter 2011

Net revenue	\$ 3,036 million	+ 5%
Operating income (EBIT)	\$ 445 million	+ 5%
Net income attributable to Fresenius Medical Care AG & Co. KGaA	\$ 221 million	+ 5%
Earnings per share	\$ 0.73	+ 4%
Total assets1	\$ 18,114 million
Operating cash flow	\$ 175 million
Employees1	74,844	+ 2%
Patients1	216,942	+ 9%
Clinics1	2,769	+ 8%
Treatments2	8.17 million	+ 9%

1 as of March 31, 2011 2

in the first quarter of 2011

Revenue Q1 2011 per region (\$ 3,036 m)

Goals for 2011

Net revenue	> \$ 13.0 billion
Net income	\$ 1.070 - 1.090 billion
Leverage ratio (Debt/EBITDA)	≤ 2.8
Capital expenditures	~ 5% of revenue
Acquisitions	~ \$ 1.2 billion

Management Board Supervisory Board

• Dr. Ben J. Lipps (Chairman) Dr. Gerd Krick (Chairman)

• Roberto Fusté Rolf A. Classon

• Dr. Emanuele Gatti William P. Johnston

• Kent Wanzek

• Rice Powell (Vice Chairman) Dr. Dieter Schenk (Vice Chairman)

• Michael Brosnan Dr. Walter L. Weisman
• Dr. Rainer Runte Prof. Dr. Bernd Fahrholz

Share Profile – Key Data

	Ordinary shares	Preference shares
Ticker Symbols
Frankfurt Stock Exchange	FME	FME3
New York Stock Exchange (NYSE)	FMS	FMS/P
Reuters: XETRA / Frankfurt Stock Exchange	FMEG.DE / FMEG.F	FMEG_p.DE / FMEG_p.F
Bloomberg	FME GY	FME3 GY
Security Identification Numbers
WKN	578 580	578 583
ISIN	DE 0005785802	DE 0005785836
CUSIP No. (NYSE)	358029106	358029205

Financing Instruments and Maturity Profile

	Year issued	Amount	Coupon %	Maturity
		in million
Credit Agreement Term Loan A	2006	\$ 1,8501		March 31, 2013
Credit Agreement Term Loan B	2006	\$ 1,7501		March 31, 2013
Senior Notes 2010 - 2016	2010	€ 250	5,50%	July 15, 2016
Senior Notes 2007 - 2017	2007	\$ 500	6,875%	July 15, 2017
Senior Notes 2011 - 2021	2011	\$ 650	5,75%	February 15, 2021
Senior Notes 2011 - 2021	2011	€ 300	5,25%	February 15, 2021
Trust Preferred Securities IV	2001	\$ 225	7,875%	June 15, 2011
Trust Preferred Securities V	2001	€ 300	7,375%	June 15, 2011
Notes (Schuldscheindarlehen)	2009	€ 155		October 27, 2012
Notes (Schuldscheindarlehen)	2009	€ 45		October 27, 2014

1 at the beginning before amortisation and extension

Share Price Development last 12 months Financial Calendar

Capital Structure Contacts

	Event	Date
52,00	Report on Second Quarter 2011
50,00	Earnings Release:	August 2, 2011
48,00	Conference Call:	August 2, 2011
46,00	Quarterly Financial Report:	August 31, 2011
44,00	Report on Third Quarter 2011
42,00	Earnings Release:	Nov. 2, 2011
40,00 38,00	Conference Call:	Nov. 2, 2011
01.05.2010 01.08.2010 01.11.2010 01.02.2011 01.05.2011	Quarterly Financial Report:	Nov. 30, 2011

Fresenius Medical Care AG & Co. KGaA Else-Kröner-Straße 1	Investor Relations & Corporate Communications 61352 Bad Homburg
Oliver Maier Senior Vice President, Head of IR & CC	P:+49(0)6172-609-2525 F: +49(0)6172-609-2301
Gerrit Jost Director	P:+49(0)6172-609-5216
North America Terry L. Morris Vice President	P:+1-800-948-2538 F: +1-615-345-5605